The BankNordik share is up by ~8% over the past week and ~24% YTD adjusted for the dividend payout i...
Redeye comments on the news that Norse Impact has reached an agreement with DAGAB on the supply of d...
Aptahem genomför nu en företrädesemission med teckningsperiod 14 – 28 juni.
Redeye provides a research update following the Q3 report published by Newbury yesterday.
Lovande resultat Nyligen presenterades fas 2a-resultat för IP2018 inom erektil dysfunktion i 24 yngr...
AcouSort möjliggör automatiserad provberedning med hjälp av sin unika ljudvågsteknologi, vilket få e...
Finnair issued a positive profit warning, and although the revision wasn’t a big surprise it came re...
Redeye comments on Alligator Bioscience following the rights issue and Q1 report.
Redeye comments on the news of Mestro's signing of Pandox as a new customer.
Redeye comments on today’s news from Nitro Games, where the company announced plans to arrange a rig...
Redeye comments on Sensys Gatso’s 2023 financial guidance.
Redeye comments on Embracer Groups restructuring initiatives for FY 2023/24e, starting immediately w...
Analyst Group har idag publicerat en analysartikel avseende TEQCool.
Redeye leaves its comments on Xspray following the investor day held last week, which shed light on ...
Speqtas vd, Fredrik Lindros, har tillsammans med BrightBids vd, Gustav Westman, presenterat förvärve...
Redeye comments on the recently announced orders from Sensys Gatso.
Redeye resumes its coverage of Alligator following the rights issue adding SEK 181m (before transact...
Biovica has signed a provider contract with Contigo Health ConfigureNet provider network.
Redeye provides an updated take on its outlooks for Integrum.
Redeye provides a preview ahead of ES Q4 2022/23 report, due on the 16th of June.
